Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $154.4800 (0.67%) ($154.4800 - $154.4800) on Tue. Apr. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.2% (three month average) | RSI | 44 | Latest Price | $154.4800(0.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.6% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.6% (StdDev 5.2%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $155.46 | 5 Day Moving Average | $152.8(1.1%) | 10 Day Moving Average | $151.62(1.89%) | 20 Day Moving Average | $155.46(-0.63%) | To recent high | -28.4% | To recent low | 50.3% | Market Cap | $2.483b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |